In last trading session, SpringWorks Therapeutics Inc (NASDAQ:SWTX) saw 0.65 million shares changing hands with its beta currently measuring 0.85. Company’s recent per share price level of $42.12 trading at $0.39 or 0.93% at ring of the bell on the day assigns it a market valuation of $3.13B. That closing price of SWTX’s stock is at a discount of -28.02% from its 52-week high price of $53.92 and is indicating a premium of 45.39% from its 52-week low price of $23.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.55 million shares which gives us an average trading volume of 1.09 million if we extend that period to 3-months.
For SpringWorks Therapeutics Inc (SWTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.11. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.64 in the current quarter.
SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information
Upright in the green during last session for gaining 0.93%, in the last five days SWTX remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $42.12 price level, adding 0.61% to its value on the day. SpringWorks Therapeutics Inc’s shares saw a change of 15.40% in year-to-date performance and have moved 16.03% in past 5-day. SpringWorks Therapeutics Inc (NASDAQ:SWTX) showed a performance of 38.19% in past 30-days. Number of shares sold short was 12.29 million shares which calculate 9.96 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 76 to the stock, which implies a rise of 44.58% to its current value. Analysts have been projecting 50 as a low price target for the stock while placing it at a high target of 76. It follows that stock’s current price would drop -18.71% in reaching the projected high whereas dropping to the targeted low would mean a loss of -18.71% for stock’s current value.
SpringWorks Therapeutics Inc (SWTX) estimates and forecasts
Statistics highlight that SpringWorks Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 1.59% of value to its shares in past 6 months, showing an annual growth rate of 39.42% while that of industry is 17.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 3,346.53% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 57.13M for the same. And 5 analysts are in estimates of company making revenue of 68.7M in the next quarter. Company posted 5.45M and 21.01M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -65.72% during past 5 years.
SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s Major holders
Insiders are in possession of 2.01% of company’s total shares while institution are holding 116.64 percent of that, with stock having share float percentage of 119.03%. Investors also watch the number of corporate investors in a company very closely, which is 116.64% institutions for SpringWorks Therapeutics Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at SWTX for having 11.11 million shares of worth $418.6 million. And as of 2024-06-30, it was holding 15.0638 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 6.54 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8715 of outstanding shares, having a total worth of $246.53 million.
On the other hand, Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 3.58 shares of worth $148.32 million or 4.81% of the total outstanding shares. The later fund manager was in possession of 2.08 shares on Jun 30, 2024 , making its stake of worth around $86.23 million in the company or a holder of 2.79% of company’s stock.
